Evidence map›Paper›PMID 34109283›Full record

ArticleJournal of health and social sciences2020

HCV and HIV co-infection among people who inject drugs in Vietnam.

Vu Toan Thinh, Li Li, Dréan Matthieu, Van Dinh Hoa, Nguyen Huu Anh, Le Minh Giang

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Journal of health and social sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Vu Toan ThinhM.Sc, Center for Research and Training on Substance Use-HIV, Hanoi Medical University, Hanoi 100000, Vietnam.
Li LiProfessor, Semel Institute for Neuroscience and Human Behavior - Center for Community Health, University of California, Los Angeles, CA 90024, USA.
Dréan MatthieuMédecins du Monde in Vietnam, Hanoi 100000, Vietnam.
Van Dinh HoaM.D., M.P.H, Center for Research and Training on Substance Use-HIV, Hanoi Medical University, Hanoi 100000, Vietnam.
Nguyen Huu AnhM.D., M.P.H, Center for Research and Training on Substance Use-HIV, Hanoi Medical University, Hanoi 100000, Vietnam.
Le Minh GiangM.D., Associate Professor, Center for Research and Training on Substance Use-HIV, Hanoi Medical University, Hanoi 100000, Vietnam.
Hanoi Medical University · VNOklahoma State University Center for Health Sciences · USViet Duc Hospital · VN

Funding

UCLA/Vietnam Training Program in Evaluation and Advanced MethodologiesD43TW010057 · FIC · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LI, LI · 2016 to 2020
$1.5M
FIC NIH HHS D43 TW010057
6 · The paper itself

Abstract

introductionHIV/HCV co-infection in people who inject drugs (PWID) continues to be a major challenge for health care systems and the PWID themselves. PWID have driven the HIV epidemic in Vietnam but information on HIV/HCV co-infection is limited.

methodsA cross-sectional study was conducted with 509 PWID recruited in Hanoi from February 2016 to April 2017. Four mutually exclusive groups were defined based on the presence of detectable HCV RNA and positive HIV confirmation. Multiple logistic regression analyses were performed to explore life-time risk behaviors of HCV mono-infection and HIV/HCV co-infection.

resultsThe overall prevalence of HIV and HCV infection was 51.08% and 61.69%, respectively. The prevalence of HCV mono-infection and HIV/HCV co-infection was 22.59% and 39.1%, respectively. We found that engaging in methadone maintenance treatment (MMT) was positively associated with HCV mono-infection (aOR = 2.38, 95% Confidential Interval [CI] 1.07 to 5.28) and with at least either HIV or HCV infection (aOR = 2.22, 95% CI 1.08 to 4.56). Ever being incarcerated was significantly associated with HCV mono-infection (aOR = 2.56, 95% CI 1.33 to 4.90) and HIV/HCV co-infection (aOR = 1.90, 95% CI 1.04 to 3.46). Those who had ever shared with and reused syringes/needles were more likely to have HIV/HCV co-infection (aORs = 5.17 and 2.86,

conclusionCorrelates for HCV mono-infection and HIV/HCV co-infection highlight the need to address risk behaviors, expand MMT programs, and establish HCV sentinel surveillance. The high prevalence of HCV and/or HIV co-infection shows a need for access to HCV treatment.

Indexed as

HCV mono-infectionHIV/HCV co-infectionPeople Who Inject DrugsVietnam

Identifiers

PMID34109283
PMCPMC8186291
OpenAlexW3172695225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.